Dapagliflozin Alleviates Diabetic Kidney Disease via Hypoxia Inducible Factor 1α/Heme Oxygenase 1-Mediated Ferroptosis
Antioxidants & Redox Signaling · 2024-03 · 40 (7-9) · 492-509
DOI: 10.1089/ars.2022.0169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 05.06.2023. Verfasst von Yi-Hui Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Ferroptosis, Diabetes Mellitus, Benzhydryl Compounds. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
Aims
Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) showed excellent renoprotective effects; however, the underlying mechanism remains not fully understood. Previous studies have revealed the importance of ferroptosis, which is closely related to oxidative stress, in the progression of DKD. In the current study, we hypothesized that SGLT2i could relieve ferroptosis and thereby alleviate renal injury in DKD due to their antioxidative stress effects.
Results
Typical changes of ferroptosis including massive lipid peroxidation, compromised antioxidant capability, and iron overload were found in db/db mice and high glucose/high fat (HG/HF)-treated HK-2 cells. Furthermore, increased expression of hypoxia inducible factor 1α (HIF1α) and heme oxygenase 1 (HO1) was observed in db/db mice and HG/HF-treated HK-2 cells as well. Dapagliflozin treatment significantly ameliorated the ferroptosis-related changes via attenuating overactivation of the HIF1α/HO1 axis in vivo and in vitro . Besides, downregulation of the HIF1α/HO1 axis alleviated ferroptosis, while overexpression of HIF1α and HO1 aggravated ferroptosis induced by HG/HF in HK-2 cells. Innovation and Conclusion: This study revealed that SGLT2i played a renoprotective role in DKD, at least in part, through alleviating HIF1α/HO1-mediated ferroptosis. Antioxid. Redox Signal. 40, 492–509.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of Chronic Kidney Diseas…
- Peking-Tsinghua Center for Life Sciences, Beijing, China.
- Research Units of Diagnosis and Treatment of Immune-Mediated Kidney Diseases, Chinese Academy of Medical Sciences, Beijing, China.
ORCID-Profile: Yi-Hui Wang
Zitieren
APA
Wang, Y. H., Chang, D. Y., Zhao, M. H., & Chen, M. (2024). Dapagliflozin Alleviates Diabetic Kidney Disease via Hypoxia Inducible Factor 1α/Heme Oxygenase 1-Mediated Ferroptosis. Antioxidants & Redox Signaling, 40(7-9), 492-509. https://doi.org/10.1089/ars.2022.0169
Vancouver
Wang YH, Chang DY, Zhao MH, Chen M. Dapagliflozin Alleviates Diabetic Kidney Disease via Hypoxia Inducible Factor 1α/Heme Oxygenase 1-Mediated Ferroptosis. Antioxidants & Redox Signaling. 2024;40(7-9):492-509. doi:10.1089/ars.2022.0169
BibTeX
@article{Wang2024,
author = {Wang, Yi-Hui and Chang, Dong-Yuan and Zhao, Ming-Hui and Chen, Min},
title = {Dapagliflozin Alleviates Diabetic Kidney Disease via Hypoxia Inducible Factor 1α/Heme Oxygenase 1-Mediated Ferroptosis},
journal = {Antioxidants & Redox Signaling},
year = {2024},
volume = {40},
number = {7-9},
pages = {492--509},
doi = {10.1089/ars.2022.0169}
}
EUVIMED